We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+9.6%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$72.7B
AUM Growth
+$7.54B
(+12%)
Cap. Flow
-$3.34B
Cap. Flow
% of AUM
-4.6%
Top 10 Holdings %
Top 10 Hldgs %
23.55%
Holding
2,585
New
253
Increased
940
Reduced
728
Closed
298
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$536M |
| 2 |
Procter & Gamble
PG
|
+$358M |
| 3 |
CSX Corp
CSX
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$186M |
| 5 |
Eli Lilly
LLY
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$370M |
| 2 |
American Electric Power
AEP
|
+$338M |
| 3 |
Alibaba
BABA
|
+$322M |
| 4 |
Prologis
PLD
|
+$307M |
| 5 |
HEICO Corp
HEI
|
+$287M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.03% |
| 2 | Financials | 13.75% |
| 3 | Industrials | 12.1% |
| 4 | Healthcare | 10.45% |
| 5 | Consumer Discretionary | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Cintas
CTAS
$81.3B
| $19.9M | 0.03% |
89,217
+23,525
| +36% | +$5.06M |
|
302
Tenet Healthcare
THC
$21.1B
| $19.6M | 0.03% |
111,397
+28,431
| +34% | +$4.28M |
|
303
Simon Property Group
SPG
$72.3B
| $19.4M | 0.03% |
120,988
+17,154
| +17% | +$2.71M |
|
|
IIF
304
Morgan Stanley India Investment Fund
IIF
$220M
| $19.3M | 0.03% |
684,428
+96,761
| +16% | +$2.53M |
|
305
F5
FFIV
$22.7B
| $19M | 0.03% |
64,578
-22,049
| -25% | -$6.09M |
|
306
Maplebear
CART
$11.8B
| $18.6M | 0.03% |
411,396
+401,851
| +4,210% | +$17.5M |
|
307
Allegion
ALLE
$14.4B
| $18.4M | 0.03% |
127,943
+37,068
| +41% | +$5.07M |
|
308
Gen Digital
GEN
$17.5B
| $18.2M | 0.03% |
617,472
+354,627
| +135% | +$9.69M |
|
309
Gold Fields
GFI
$36.5B
| $18.1M | 0.03% |
766,031
+324,134
| +73% | +$7.45M |
|
310
Automatic Data Processing
ADP
$108B
| $18.1M | 0.02% |
58,723
-40,159
| -41% | -$12.3M |
|
311
Bankunited
BKU
$3.36B
| $17.9M | 0.02% |
504,363
-13,322
| -3% | -$447K |
|
312
General Motors
GM
$76.8B
| $17.9M | 0.02% |
364,501
-15,507
| -4% | -$735K |
|
313
Pinterest
PINS
$13.4B
| $17.8M | 0.02% |
497,012
+99,779
| +25% | +$3.03M |
|
314
GE Vernova
GEV
$264B
| $17.8M | 0.02% |
33,607
+14,954
| +80% | +$6.23M |
|
315
KE Holdings
BEKE
$18.8B
| $17.7M | 0.02% |
999,133
+64,078
| +7% | +$1.23M |
|
316
Mine Safety
MSA
$7.49B
| $17.7M | 0.02% |
105,802
+1,976
| +2% | +$309K |
|
317
Allstate
ALL
$67.5B
| $17.4M | 0.02% |
86,679
+66,267
| +325% | +$13.2M |
|
318
Bristol-Myers Squibb
BMY
$132B
| $17.4M | 0.02% |
375,137
+84,484
| +29% | +$4.15M |
|
|
MXF
319
Mexico Fund
MXF
$315M
| $17.3M | 0.02% |
984,071
-27,600
| -3% | -$440K |
|
320
Cboe Global Markets
CBOE
$29.9B
| $17.1M | 0.02% |
73,436
+23,785
| +48% | +$5.3M |
|
321
JD.com
JD
$44.5B
| $16.8M | 0.02% |
515,263
-5,131,939
| -91% | -$175M |
|
322
Vaxcyte
PCVX
$8.64B
| $16.6M | 0.02% |
512,135
-45,659
| -8% | -$1.5M |
|
323
Atlassian
TEAM
$37.8B
| $16.6M | 0.02% |
81,889
+16,679
| +26% | +$3.47M |
|
324
BlackRock Resources & Commodities Strategy Trust
BCX
$923M
| $16.4M | 0.02% |
1,740,502
-263,930
| -13% | -$2.4M |
|
|
EAGL
325
Eagle Capital Select Equity ETF
EAGL
$4.62B
| $16.3M | 0.02% |
539,338
+312,291
| +138% | +$8.79M |
|
Similar funds
QCM
Lazard Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Lazard Asset Management held 2,585 positions worth $72.7B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $3.34B in Q2 2025, closing 298 positions and reducing 728 holdings. Its most notable exit was Eastman Chemical, an estimated $13.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Industrials.
Against the trend, Lazard Asset Management opened a new position in Arcos Dorados Holdings worth $117M.
- Lazard Asset Management's largest Q2 2025 buy was Arcos Dorados Holdings: 14,873,278 shares worth $117M.
- Lazard Asset Management added most to Crown Castle in Q2 2025, an estimated $536M increase.
- Lazard Asset Management's biggest Q2 2025 reduction was NetEase, cutting an estimated $370M.
- Lazard Asset Management fully exited Eastman Chemical in Q2 2025, selling an estimated $13.1M.
- Lazard Asset Management's ten largest holdings make up 24% of its $72.7B portfolio in Q2 2025.
- Lazard Asset Management opened 253 new positions and closed 298 in Q2 2025.
- Lazard Asset Management's portfolio value rose 12% quarter-over-quarter to $72.7B.
Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.